Sera Prognostics (SERA) Change in Account Payables (2020 - 2026)
Sera Prognostics (SERA) reported Change in Account Payables of -$70000.0 for Q1 2026, up 92.97% on a YoY basis from -$36274.7 in Q1 2025, and up 25.53% quarter-over-quarter from -$94000.0 in Q4 2025.
Sera Prognostics (SERA) Change in Account Payables (2020 - 2026) Analysis & Trends
Sera Prognostics has reported Change in Account Payables for 7 years, with the latest figure at -$70000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 92.97% year-over-year to -$70000.0; the trailing twelve-month figure through Mar 2026 stood at -$83000.0 (up 83.85% YoY), and the FY2025 full-year result was -$1.0 million, down 321.76% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$70000.0, up from -$94000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $556000.0 in Q4 2022, with the low at -$996000.0 in Q1 2025.
- Historically, Change in Account Payables has averaged -$42000.0 across 5 years, with a median of -$15000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 554.12% — and 2025, when it plunged 3588.89%.
- Sera Prognostics' Change in Account Payables stood at $556000.0 in 2022, then sank by 132.37% to -$180000.0 in 2023, then soared by 312.22% to $382000.0 in 2024, then slumped by 124.61% to -$94000.0 in 2025, then climbed by 25.53% to -$70000.0 in 2026.
- The last three Change in Account Payables figures came in at -$70000.0 (Q1 2026), -$94000.0 (Q4 2025), and $52000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Sera Prognostics | 93.48 Mn | 93.48 Mn | -28,000.00 | -70,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -70,000.00 |
| Mar 31, 2026 | -70,000.00 |
| Dec 31, 2025 | -94,000.00 |
| Dec 31, 2025 | -94,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Sep 30, 2025 | 52,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Jun 30, 2025 | 29,000.00 |
| Mar 31, 2025 | -996,000.00 |
| Mar 31, 2025 | -996,000.00 |
| Dec 31, 2024 | 382,000.00 |
| Dec 31, 2024 | 382,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Sep 30, 2024 | 115,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Jun 30, 2024 | -15,000.00 |
| Mar 31, 2024 | -27,000.00 |
| Mar 31, 2024 | -27,000.00 |
| Dec 31, 2023 | -180,000.00 |
| Dec 31, 2023 | -180,000.00 |